The practice of routinely maintaining PIVC access has not only benefits but also risks. It’s due for a mindset shift, with ...
Concerns arise over IV cannula quality in Tamil Nadu hospitals, with incidents of breakage leaving fragments inside patients’ veins.
Novel platform combining imaging, AI, and robotics aims to enhance IV placement success rates and patient experience ...
PHM continues to advance with diverse research impacting clinical care, quality improvement, and health equity. The top 10 ...
"A patient undergoing IV therapy at Ebo2 Therapy and Wellness in Los Angeles."Los Angeles medical facility documents significant recovery rates in peripheral neuropathy patients using EBOO blood ...
FDA Established April 23, 2026 as PDUFA Target Date for Review of Submission Seeking Approval for GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) ...
A look at the diagnostic approach to canine vestibular disease, from the initial exam to the challenges of peripheral vs.
OverviewThe global vascular access device (VAD) market is projected to grow steadily at a CAGR of ~6% during the forecast ...
GEN2 was evaluated in adult patients with advanced solid tumors in an intravenous dose escalation Phase 1 study GEN2 is well-tolerated, with no ...
Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.
Breaking PresentationPRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, ...
The forecasted growth highlights significant opportunities for manufacturers to engage in a rapidly evolving market that is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback